The role of mitochondrial DNA alterations in esophageal squamous cell carcinomas

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 1, 2010, Pages

  Lin, Chen Sung ^a,b,c   Chang, Shi Chuan ^a,c   Wang, Liang Shun ^a,e   Chou, Teh Ying ^a,d   Hsu, Wen Hu ^a,c   Wu, Yu Chung ^a,c   Wei, Yau Huei ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b KEELUNG HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d Laboratory Medicine   (Taiwan)

^e EN CHU KONG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MITOCHONDRIAL DNA;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CIGARETTE SMOKING; DNA EXTRACTION; DNA SEQUENCE; DRINKING BEHAVIOR; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS; ESOPHAGUS MUCOSA; FEMALE; GENE NUMBER; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SOMATIC MUTATION; WINE;

EID: 73149096510     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.04.007     Document Type: Article

References (25)

1. Wang L.S., Chow K.C., Chi K.H., Liu C.C., Li W.Y., Chiu J.H., et al. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am J Gastroenterol 94 (1999) 1933-1940
2. Hsu C.P., Chen C.Y., Hsia J.Y., and Shai S.E. Prediction of prognosis by the extent of lymph node involvement in squamous cell carcinoma of the thoracic esophagus. Eur J Cardiothorac Surg 19 (2001) 10-13
3. Lin C.S., Chang S.C., Wei Y.H., Chou T.Y., Wu Y.C., Lin H.C., et al. Prognostic variables in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg 87 (2009) 1056-1065
4. Lightowlers R.N., Chinnery P.F., Turnbull D.M., and Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet 13 (1997) 450-455
5. Lee H.C., and Wei Y.H. Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp Biol Med (Maywood) 232 (2007) 592-606
6. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39 (2005) 359-407
7. Moraes C.T. What regulates mitochondrial DNA copy number in animal cells?. Trends Genet 17 (2001) 199-205
8. Mambo E., Gao X., Cohen Y., Guo Z., Talalay P., and Sidransky D. Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations. Proc Natl Acad Sci U S A 100 (2003) 1838-1843
9. Andrews R.M., Kubacka I., Chinnery P.F., Lightowlers R.N., Turnbull D.M., and Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23 (1999) 147
10. Sanchez-Cespedes M., Parrella P., Nomoto S., Cohen D., Xiao Y., Esteller M., et al. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 61 (2001) 7015-7019
11. Lee H.C., Yin P.H., Lin J.C., Wu C.C., Chen C.Y., Wu C.W., et al. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann NY Acad Sci 1042 (2005) 109-122
12. Abnet C.C., Huppi K., Carrera A., Armistead D., McKenney K., Hu N., et al. Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma. BMC Cancer 4 (2004) 30
13. Kumimoto H., Yamane Y., Nishimoto Y., Fukami H., Shinoda M., Hatooka S., et al. Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int J Cancer 108 (2004) 228-231
14. Kim M.M., Clinger J.D., Masayesva B.G., Ha P.K., Zahurak M.L., Westra W.H., et al. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin Cancer Res 10 (2004) 8512-8515
15. Lee H.C., Li S.H., Lin J.C., Wu C.C., Yeh D.C., and Wei Y.H. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res 547 (2004) 71-78
16. Wu C.W., Yin P.H., Hung W.Y., Li A.F., Li S.H., Chi C.W., et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer 44 (2005) 19-28
17. Tseng L.M., Yin P.H., Chi C.W., Hsu C.Y., Wu C.W., Lee L.M., et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer 45 (2006) 629-638
18. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. (2002), Lippincott-Raven, Philadelphia
19. Bough K.J., Mott D.D., and Dingledine R.J. Medial perforant path inhibition mediated by mGluR7 is reduced after status epilepticus. J Neurophysiol 92 (2004) 1549-1557
20. Hung W.Y., Lin J.C., Lee L.M., Wu C.W., Tseng L.M., Yin P.H., et al. Tandem duplication/triplication correlated with poly-cytosine stretch variation in human mitochondrial DNA D-loop region. Mutagenesis 23 (2008) 137-142
21. Lin C.S., Wang L.S., Tsai C.M., and Wei Y.H. Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapy. Interact Cardiovasc Thorac Surg 7 (2008) 954-958
22. Lievre A., Blons H., Houllier A.M., Laccourreye O., Brasnu D., Beaune P., et al. Clinicopathological significance of mitochondrial D-loop mutations in head and neck carcinoma. Br J Cancer 94 (2006) 692-697
23. Suzuki M., Toyooka S., Miyajima K., Iizasa T., Fujisawa T., Bekele N.B., et al. Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res 9 (2003) 5636-5641
24. Nowell P.C. The clonal evolution of tumor cell populations. Science 194 (1976) 23-28
25. Warburg O. On respiratory impairment in cancer cells. Science 124 (1956) 269-270